ACCESSION: MSBNK-SMB_Measured-HSA001P0099001
RECORD_TITLE: Uncharacterized; LC-ESI-QFT; MS2; POSITIVE; Averaged data
DATE: 2025.04.02 (Averaged 2025.02.17, Processed 2025.02.17, Annotated 2025.03.05, Curated 2025.04.02)
AUTHORS: Shin-MassBank project
LICENSE: CC BY-NC-SA
PUBLICATION: Shin-MassBank project in preparation
COMMENT: This is an averaged mass spectra data created by averaging product ion scan data obtained from the following DDA dataset.
COMMENT: REPOSITORY MB-POST
COMMENT: DATASET_ID MPST000004
COMMENT: DATASET_TITLE Annotation of various metabolites in SRM 1950 human serum
COMMENT: DATASET_AUTHORS Masatomo Takahashi, Yoshihiro Izumi, Kyoshu University
COMMENT: MS1_M/Z_AVERAGED_THRES 0.750
COMMENT: MS2_M/Z_AVERAGED_THRES 4.000
COMMENT: DATASET_FILE_NUM 22
COMMENT: NUM_AVERAGED_SPEC 39
COMMENT: RAW_SPEC {'BLK01_293': {'bp': 283095.0, 'sum': 815485.0}, 'BLK01_418': {'bp': 253692.0, 'sum': 757899.0}, 'BLK01_166': {'bp': 252357.0, 'sum': 811030.0}, 'BLK01_81': {'bp': 242808.0, 'sum': 799186.0}, '7_posi_188': {'bp': 236243.0, 'sum': 618658.0}, '19_posi_354': {'bp': 228627.0, 'sum': 599138.0}, '4_posi_125': {'bp': 228291.0, 'sum': 645207.0}, '14_posi_83': {'bp': 227059.0, 'sum': 650410.0}, '12_posi_271': {'bp': 222663.0, 'sum': 639135.0}, '17_posi_104': {'bp': 220119.0, 'sum': 664214.0}, '14_posi_187': {'bp': 220109.0, 'sum': 636863.0}, 'BLK01_691': {'bp': 219379.0, 'sum': 744107.0}, '9_posi_82': {'bp': 215922.0, 'sum': 643462.0}, '15_posi_335': {'bp': 215790.0, 'sum': 638425.0}, '19_posi_167': {'bp': 213809.0, 'sum': 617788.0}, '18_posi_208': {'bp': 212663.0, 'sum': 606721.0}, '16_posi_81': {'bp': 210586.0, 'sum': 613947.0}, '17_posi_355': {'bp': 207559.0, 'sum': 596703.0}, '10_posi_121': {'bp': 207327.0, 'sum': 653696.0}, '7_posi_293': {'bp': 206879.0, 'sum': 579373.0}, '9_posi_228': {'bp': 202078.0, 'sum': 589391.0}, '11_posi_314': {'bp': 201473.0, 'sum': 591724.0}, '18_posi_310': {'bp': 200682.0, 'sum': 541453.0}, '4_posi_376': {'bp': 197080.0, 'sum': 577369.0}, '8_posi_124': {'bp': 195477.0, 'sum': 573565.0}, '16_posi_230': {'bp': 194800.0, 'sum': 560811.0}, '17_posi_185': {'bp': 194454.0, 'sum': 598807.0}, '17_posi_269': {'bp': 194023.0, 'sum': 593530.0}, '8_posi_207': {'bp': 193704.0, 'sum': 598764.0}, '12_posi_82': {'bp': 192253.0, 'sum': 613111.0}, '19_posi_83': {'bp': 191419.0, 'sum': 590616.0}, '18_posi_82': {'bp': 191201.0, 'sum': 626046.0}, '15_posi_208': {'bp': 187589.0, 'sum': 584023.0}, '11_posi_123': {'bp': 184157.0, 'sum': 535842.0}, '19_posi_250': {'bp': 176305.0, 'sum': 571726.0}, '16_posi_374': {'bp': 171036.0, 'sum': 525640.0}, '5_posi_314': {'bp': 170638.0, 'sum': 510852.0}, '14_posi_355': {'bp': 163195.0, 'sum': 540798.0}, '7_posi_419': {'bp': 157161.0, 'sum': 492340.0}}
COMMENT: RETENTION_TIME_STDEV 0.261
COMMENT: PRECURSOR_M/Z_RAW 99.055496
COMMENT: PRECURSOR_M/Z_STDEV 0.000030
COMMENT: PRECURSOR_IN_MS1 ND
COMMENT: PROPOSED_CHARGE_STATE ND
COMMENT: PROPOSED_ISOTOPE_STATE ND
COMMENT: PROPOSED_MAX_NUM_S 0
COMMENT: PROPOSED_MF SevenGoldenRules 0.245; C4H6N2O; [M+H]+; delta(ppm) 0.244778
COMMENT: PROPOSED_MF MS-FINDER 3.466; C4H6N2O; [M+H]+; delta(ppm) 0.239663
COMMENT: PROPOSED_MF SIRIUS5_Sirius 21.072; C4H6N2O; [M+H]+; delta(ppm) 0.239663
COMMENT: PROPOSED_MF SIRIUS5_Zodiac 1.000; C4H6N2O; [M+H]+; delta(ppm) 0.239663
COMMENT: PROPOSED_MF SIRIUS6_Sirius 26.462; C4H6N2O; [M+H]+; delta(ppm) 0.239663
COMMENT: PROPOSED_MF SIRIUS6_Sirius -4.234; C2H4N5; [M+H]+; delta(ppm) 13.794539
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 1.000; C4H6N2O; [M+H]+; delta(ppm) 0.239663
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.376; FKPXGNGUVSHWQQ-UHFFFAOYSA-N; [M+H]+; 3-Isoxazolamine (Int.3)
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.376; SDFAQCKICUGIJO-UHFFFAOYSA-N; [M+H]+; Pelopuradazole
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.369; JRMKJOOJKCAEJK-UHFFFAOYSA-N; [M+H]+; 4-Hydroxymethylpyrazole
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.358; LIHUTSFYFGCWQP-UHFFFAOYSA-N; [M+H]+; 2-cyano-N-methylacetamide
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.336; LMDDHEQEFKCAJH-SGAVLPGINA-N; [M+H]+; UNPD98235
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.254; ONONIESHMTZAKB-UHFFFAOYNA-N; [M+H]+; N-(1-cyanoethyl)formamide
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.254; YVDWFZIVIIKYBQ-UHFFFAOYSA-N; [M+H]+; dimethyl-1,3,4-oxadiazole
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.237; QDYTUZCWBJRHKK-UHFFFAOYSA-N; [M+H]+; imidazole-4-methanol
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.231; NHLAPJMCARJFOG-UHFFFAOYSA-N; [M+H]+; 2,4-dihydro-5-methyl-3H-pyrazol-3-one
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 1.000; SDFAQCKICUGIJO-UHFFFAOYSA-N; [M+H]+; Pelopuradazole
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.702; NHLAPJMCARJFOG-UHFFFAOYSA-N; [M+H]+; 2,4-dihydro-5-methyl-3H-pyrazol-3-one
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.601; LMDDHEQEFKCAJH-SGAVLPGINA-N; [M+H]+; UNPD98235
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.555; JRMKJOOJKCAEJK-UHFFFAOYSA-N; [M+H]+; 4-Hydroxymethylpyrazole
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.555; QDYTUZCWBJRHKK-UHFFFAOYSA-N; [M+H]+; imidazole-4-methanol
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.193; FKPXGNGUVSHWQQ-UHFFFAOYSA-N; [M+H]+; 3-Isoxazolamine (Int.3)
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.137; YVDWFZIVIIKYBQ-UHFFFAOYSA-N; [M+H]+; dimethyl-1,3,4-oxadiazole
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.071; LIHUTSFYFGCWQP-UHFFFAOYSA-N; [M+H]+; 2-cyano-N-methylacetamide
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.071; ONONIESHMTZAKB-UHFFFAOYNA-N; [M+H]+; N-(1-cyanoethyl)formamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 3.113; QDYTUZCWBJRHKK-UHFFFAOYSA-N; [M+H]+; 1H-imidazol-5-ylmethanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.557; FKPXGNGUVSHWQQ-UHFFFAOYSA-N; [M+H]+; 5-methyl-1,2-oxazol-3-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.448; NHLAPJMCARJFOG-UHFFFAOYSA-N; [M+H]+; 3-methyl-1,4-dihydropyrazol-5-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.644; WGVHNCAJPFIFCR-UHFFFAOYSA-N; [M+H]+; 5-methyl-1,2-dihydropyrazol-3-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.536; ZOMATQMEHRJKLO-UHFFFAOYSA-N; [M+H]+; 1H-imidazol-2-ylmethanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.429; JMARSTSWTFXHMC-UHFFFAOYSA-N; [M+H]+; 2-methyl-1H-pyrazol-3-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.379; NNZXDXMEXBYSRF-UHFFFAOYSA-N; [M+H]+; 2-methyl-4H-pyrazol-3-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.333; GFLJNYQMIIBKIE-UHFFFAOYSA-N; [M+H]+; 2-(3-methyldiazirin-3-yl)acetaldehyde
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.306; JRMKJOOJKCAEJK-UHFFFAOYSA-N; [M+H]+; 1H-pyrazol-4-ylmethanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.152; MCSCIFLXNFLCDV-UHFFFAOYSA-N; [M+H]+; 4-methyl-1,3-dihydroimidazol-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.113; VCZJVXLWQTXSPQ-UHFFFAOYSA-N; [M+H]+; 4-methyl-1,3-oxazol-2-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.105; YVDWFZIVIIKYBQ-UHFFFAOYSA-N; [M+H]+; 2,5-dimethyl-1,3,4-oxadiazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.093; NRYCMMCUURADTR-UHFFFAOYSA-N; [M+H]+; 1,2-oxazol-3-ylmethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.091; UVEDQUMYFTWIPC-UHFFFAOYSA-N; [M+H]+; N-methyl-1,2-oxazol-3-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.078; PXHFWPOPKVWXQT-UHFFFAOYSA-N; [M+H]+; 3-methyl-1H-imidazol-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.068; YWXMEOHQQJWIOZ-UHFFFAOYSA-N; [M+H]+; N-methyl-1,3-oxazol-2-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.067; IENISVMEYSGVOI-UHFFFAOYSA-N; [M+H]+; 4-methyl-1,2-oxazol-3-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.056; UIEABCXJWANXFS-UHFFFAOYSA-N; [M+H]+; 1H-pyrazol-5-ylmethanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.036; ZLKZGKDNYHEPFV-UHFFFAOYSA-N; [M+H]+; 1,3-oxazol-2-ylmethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.024; OKFHTQFXGQXDEX-UHFFFAOYSA-N; [M+H]+; 1-nitroso-2,5-dihydropyrrole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.008; WIISOYLZJJYTHT-UHFFFAOYSA-N; [M+H]+; 2-methyl-1H-pyrazol-5-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.991; ULZXEYFKBUPRQM-UHFFFAOYSA-N; [M+H]+; 1,3-oxazol-4-ylmethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.965; BNOWDJRGXLVJHD-UHFFFAOYSA-N; [M+H]+; 3-methyl-1,2-oxazol-4-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.930; FNXYWHTZDAVRTB-UHFFFAOYSA-N; [M+H]+; 3-methyl-1,2-oxazol-5-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.924; ZPIDZCBCCUTEEI-UHFFFAOYSA-N; [M+H]+; 1,3-oxazol-5-ylmethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.917; XETGVWXXGWZBDG-UHFFFAOYSA-N; [M+H]+; 1,2-oxazol-4-ylmethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.916; GWYFIIHULJCWMO-UHFFFAOYSA-N; [M+H]+; 4-methyl-1,4-dihydropyrazol-5-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.904; NJZGUJMVUBUAOC-UHFFFAOYSA-N; [M+H]+; 2-methyl-1,3-oxazol-4-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.901; FQASUNMXKLPOOF-UHFFFAOYSA-N; [M+H]+; 1-methylpyrazol-4-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.890; LJPYJRMMPVFEKR-UHFFFAOYSA-N; [M+H]+; prop-2-ynylurea
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.862; RGQMPSRGRDKMCX-UHFFFAOYSA-N; [M+H]+; 5-methyl-1H-pyrazol-4-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.858; LMDDHEQEFKCAJH-UHFFFAOYSA-N; [M+H]+; 5-amino-2H-pyrrol-2-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.714; LILTZUFNZDRURN-UHFFFAOYSA-N; [M+H]+; methyl N-cyanoethanimidate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.659; LIHUTSFYFGCWQP-UHFFFAOYSA-N; [M+H]+; 2-cyano-N-methylacetamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.549; DYYFCNDEROYKKJ-UHFFFAOYSA-N; [M+H]+; 5-methyl-1,3-oxazol-2-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.519; QGMHRTDVNDXDBB-UHFFFAOYSA-N; [M+H]+; 5-methyl-1,2-oxazol-4-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.505; NCFMDIJKEYGCRD-UHFFFAOYSA-N; [M+H]+; 4-methoxy-1H-pyrazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.491; RFOKQRIAAPEYBE-UHFFFAOYSA-N; [M+H]+; 3-aminooxetane-3-carbonitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.480; JKJSZGJVBAWEFB-UHFFFAOYSA-N; [M+H]+; 3,4-dimethyl-1,2,5-oxadiazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.460; OYNWFDBANWIYDA-UHFFFAOYSA-N; [M+H]+; 1,2-oxazol-5-ylmethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.459; DASYJICSSLWYAG-UHFFFAOYSA-N; [M+H]+; 2-cyanopropanamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.443; LHWCUMYXUCPQSZ-UHFFFAOYSA-N; [M+H]+; N-(cyanomethyl)acetamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.433; ZGSNZVRXASCXRP-UHFFFAOYSA-N; [M+H]+; 5-methoxy-1H-pyrazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.423; GYNLTWUPSJGXFV-UHFFFAOYSA-N; [M+H]+; 4-methyl-1,2-oxazol-5-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.419; MWIGGUZSIJZLJM-UHFFFAOYSA-N; [M+H]+; ethyl N-cyanomethanimidate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.414; YXSUIVZFLAJASX-UHFFFAOYSA-N; [M+H]+; 5-methoxy-1H-imidazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.410; ONONIESHMTZAKB-UHFFFAOYSA-N; [M+H]+; N-(1-cyanoethyl)formamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.393; VIAULTBEPNVQAG-UHFFFAOYSA-N; [M+H]+; 3-hydroxyazetidine-1-carbonitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.391; UANYAJXOOSFGOM-UHFFFAOYSA-N; [M+H]+; 3-hydroxyazetidine-3-carbonitrile
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -73.139; FKPXGNGUVSHWQQ; [M+H]+; 5-Methyl-3-isoxazolamine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -93.006; WGVHNCAJPFIFCR; [M+H]+; 3-methylpyrazol-5-ol
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -98.181; FNXYWHTZDAVRTB; [M+H]+; 3-Methyl-5-isoxazolamine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -110.148; NHLAPJMCARJFOG; [M+H]+; 3Me5Oxopyrazol
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -121.754; IENISVMEYSGVOI; [M+H]+; 4-Methylisoxazol-3-amine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -124.730; GWYFIIHULJCWMO; [M+H]+; 4-Methyl-2-pyrazolin-5-one
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -125.817; YVDWFZIVIIKYBQ; [M+H]+; dimethyl-1,3,4-oxadiazole
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -130.442; MCSCIFLXNFLCDV; [M+H]+; 4-Methyl-4-imidazolin-2-one
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -134.678; DYYFCNDEROYKKJ; [M+H]+; 5-methyloxazol-2-amine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -139.571; VCZJVXLWQTXSPQ; [M+H]+; 2-amino-4-methyloxazol
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -155.198; SDFAQCKICUGIJO; [M+H]+; 4-methyl-1,2-dihydroimidazol-5-one
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -171.905; ONONIESHMTZAKB; [M+H]+; N-(1-Cyanoethyl)formamide
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -172.018; JMARSTSWTFXHMC; [M+H]+; 2-methylpyrazol-3-ol
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -172.319; ZGSNZVRXASCXRP; [M+H]+; 5-methoxy-1H-pyrazole
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -173.413; YKAWOJYVXDCFDP; [M+H]+; 3-cyanopropanamide
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -176.532; NRYCMMCUURADTR; [M+H]+; ACMC-20adug
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -177.978; WIISOYLZJJYTHT; [M+H]+; 1-Methyl-1H-pyrazol-3-ol
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -178.440; LHWCUMYXUCPQSZ; [M+H]+; ACMC-20akam
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -181.511; LIHUTSFYFGCWQP; [M+H]+; 2-Cyano-N-methylacetamide
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -221.773; ZOMATQMEHRJKLO; [M+H]+; Imidazole-2-methanol
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -222.612; ULZXEYFKBUPRQM; [M+H]+; Oxazol-4-ylmethanamine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -224.321; LMDDHEQEFKCAJH; [M+H]+; 2-Hiacp
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -231.029; QDYTUZCWBJRHKK; [M+H]+; Lopac-H-1877
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -241.151; MWIGGUZSIJZLJM; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -242.736; UIEABCXJWANXFS; [M+H]+; 1H-pyarzole-3-methanol
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -243.510; LILTZUFNZDRURN; [M+H]+; Methyl N-cyanoacetimidate
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -255.744; FQASUNMXKLPOOF; [M+H]+; 1-Methyl-1H-pyrazol-4-ol
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -279.077; JRMKJOOJKCAEJK; [M+H]+; 1H-Pyrazole-4-methanol
COMMENT: PROPOSED_COMPOUND SIRIUS5_Confidence:biodatabase 0.417; FKPXGNGUVSHWQQ; [M+H]+; 5-Methyl-3-isoxazolamine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -66.293; NNZXDXMEXBYSRF; [M+H]+; 1-methyl-1H-pyrazol-5(4H)-one
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -80.858; SDFAQCKICUGIJO; [M+H]+; Pelopuradazole
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -95.048; RWMBKMMQEMUWEO; [M+H]+; 3,4-dihydro-1H-pyrazin-2-one
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -119.812; LJPYJRMMPVFEKR; [M+H]+; Prop-2-ynylurea
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -122.346; LHWCUMYXUCPQSZ; [M+H]+; N-(Cyanomethyl)acetamide
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -122.430; ONONIESHMTZAKB; [M+H]+; N-[1-(azanylidyne(113C)methyl)ethyl]formamide
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -123.828; GWYFIIHULJCWMO; [M+H]+; (4R)-4-methyl-1,4-dihydropyrazol-5-one
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -126.439; LILTZUFNZDRURN; [M+H]+; Ethanimidic acid, N-cyano-, methyl ester
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -126.898; MWIGGUZSIJZLJM; [M+H]+; ethyl N-(azanylidyne(114C)methyl)methanimidate
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -129.220; LIHUTSFYFGCWQP; [M+H]+; 2-Cyano-N-methylacetamide
COMMENT: PROPOSED_COMPOUND SIRIUS6_Confidence:biodatabase 0.302; NNZXDXMEXBYSRF; [M+H]+; 1-methyl-1H-pyrazol-5(4H)-one
COMMENT: CONFIDENCE Level 4: Unequivocal precursor ion formula C4H7N2O1; Top hit by both SIRIUS6_Zodiac and MS-FINDER; and SevenGoldenRules(1), SIRIUS5_Sirius(1), SIRIUS5_Zodiac(1);
CH$NAME: Uncharacterized
CH$COMPOUND_CLASS: Uncharacterized
CH$FORMULA: C39H42O2
CH$EXACT_MASS: 542.318480
CH$SMILES: CCCC#Cc1cc(C#CCCC)cc(C#Cc2cc(C#CC(C)(C)C)c(cc2C#CC(C)(C)C)C2OCCO2)c1
CH$IUPAC: InChI=1S/C39H42O2/c1-9-11-13-15-30-25-31(16-14-12-10-2)27-32(26-30)17-18-33-28-35(20-22-39(6,7)8)36(37-40-23-24-41-37)29-34(33)19-21-38(3,4)5/h25-29,37H,9-12,23-24H2,1-8H3
CH$LINK: PUBCHEM CID:11353257
SP$SCIENTIFIC_NAME: Homo sapiens
SP$LINK: NCBI-TAXONOMY 9606 
SP$SAMPLE: Serum
AC$INSTRUMENT: Nexera X2 UHPLC system, Shimadzu - Q Exactive Orbitrap, Thermo Scientific
AC$INSTRUMENT_TYPE: LC-ESI-QFT
AC$MASS_SPECTROMETRY: MS_TYPE MS2
AC$MASS_SPECTROMETRY: ION_MODE POSITIVE
AC$MASS_SPECTROMETRY: COLLISION_ENERGY 20 V
AC$MASS_SPECTROMETRY: COLLISION_GAS N2
AC$MASS_SPECTROMETRY: FRAGMENTATION_MODE CID
AC$MASS_SPECTROMETRY: ION_SPRAY_VOLTAGE 4.0 kV
AC$MASS_SPECTROMETRY: IONIZATION ESI
AC$MASS_SPECTROMETRY: MASS_ACCURACY MS1(ppm) 0.75; MS2(ppm) 4.00
AC$CHROMATOGRAPHY: COLUMN_NAME GL-HilicAex 2.1 x 150 mm, 5 mm (Resonac)
AC$CHROMATOGRAPHY: FLOW_GRADIENT B conc(%). 0 min: 95, 0.5 min: 95, 15.5 min: 40, 16.5 min: 0, 26.5 min: 0, 27.5 min: 95, 35 min: 95.
AC$CHROMATOGRAPHY: FLOW_RATE 0.4 mL/min
AC$CHROMATOGRAPHY: RETENTION_TIME 0.475
MS$FOCUSED_ION: PRECURSOR_M/Z 99.055313
MS$DATA_PROCESSING: RECALIBRATE Data dependent recalibration using whole DDA dataset
PK$SPLASH: splash10-00dj-9000000000-0360545c6c92d4646178
PK$ANNOTATION: m/z int m/z_nocal m/z_std(ppm) int_std cor n annotation
  56.0495483 59.3171 56.050180 1.2132 12.82 0.1919 39 f{C3H6N1}/1.30ppm,p-C1H1N1O1
  57.0447360 21.9604 57.045370 1.2972 7.43 0.5126 35 f{C2H5N2}/0.20ppm,p-C2H2O1
  58.0651439 38.6844 58.065780 0.8267 8.68 0.4247 39 ?
  69.0447444 292.7228 69.045370 0.3621 58.72 0.2314 39 f{C3H5N2}/0.29ppm,p-C1H2O1
  70.0651505 160.7771 70.065770 0.4995 38.79 -0.0464 39 ?
  71.0603868 999.0000 71.061000 0.2815 0.00 0.7312 39 f{C3H7N2}/0.17ppm,p-C1O1
  81.0446736 38.6382 81.045200 1.0488 7.63 0.1152 39 f{C4H5N2}/-0.63ppm,p-H2O1
  82.0480347 72.4928 82.048550 0.8410 12.84 0.2395 39 ?
  82.0650949 51.5658 82.065610 0.9870 17.79 0.4010 39 ?
  84.0681683 31.9993 84.068660 0.9754 7.01 0.4433 39 ?
  99.0553106 737.6488 99.055640 0.2625 54.48 1.0000 39 f{C4H7N2O1}/0.22ppm,p
  99.0917009 327.8655 99.092030 0.3633 44.49 0.5644 39 ?
PK$NUM_PEAK: 12
PK$PEAK: m/z int. rel.int.
  56.049548 59.32 59
  57.044736 21.96 21
  58.065144 38.68 38
  69.044744 292.72 292
  70.065150 160.78 160
  71.060387 999.00 999
  81.044674 38.64 38
  82.048035 72.49 72
  82.065095 51.57 51
  84.068168 32.00 31
  99.055311 737.65 737
  99.091701 327.87 327
//
